higher). Thus Board approval and SET disclosure is required. (Net tangible asset value of the Company in the consolidated financial statements as at 30th June 2019 is Baht 5,675 million) 3.2 Basis used to
, 2017 at UHT production line, located in Navanakorn Industrial Estate of Baht 68 million. Net Profit Net profit of Q2’2018 was Baht 244 million, decreased by Baht 173 million or 41.6%, mainly from
was held on 11 May 2018 at 18.00 hrs., the Company would like to notify the significant resolution of the meeting, as follows: The Board of Directors’ meeting has resolved to approve Sapphire RoRo
stood at 27.8%. An increase of net profit was a result of the Company has higher revenues from collection of purchased accounts receivables. Thus, the details of the Company group can be described as
36.27%, increase by 0.70% The result of 1 and 2 make a decrease of 498.25 million baht in gross profit. 3. In the second quarter of 2018, the Company sold a property in USA at selling price of 4,544.13
Baht, decline in investment money in affiliate company as amount of 20.45 Million Baht and decrease in deferred income tax of 20.41 Million Baht Source of Investment Liabilities As at June 30, 2018 the
Laboratories Co., Ltd. is a listed company established in the year 1971. The manufacture and distribution of conventional medicine. Office and Factory are located at No.47 Soi Boonchana, Sukhumvit 59, Klong Ton
Tangjaruwatanachai and (3) Mr. Panwarit Martmueang (collectively referred to as the “Sellers”), who currently and collectively hold 60 percent of the total shares in GSG, at a total purchase price of THB 240,000,000
, 2018. 2 token holders. Although such limit is imposed in the primary market, investors will still be able to obtain ICO tokens in the secondary market and potentially at a much higher cost. Regulatory
fabric and then to produce plastic sacks. In which plastic fabric products are upstream products There are many vendors. It has low added value and gross profit margin and can be purchased at market prices